Provided by Tiger Fintech (Singapore) Pte. Ltd.

89Bio, Inc.

11.00
+0.22002.04%
Post-market: 11.100.1000+0.91%18:51 EDT
Volume:1.44M
Turnover:15.69M
Market Cap:1.61B
PE:-3.34
High:11.14
Open:10.70
Low:10.58
Close:10.78
Loading ...

FDA Accepts Sanofi's Filing for Multiple Sclerosis Drug Tolebrutinib

Zacks
·
25 Mar

Elevation Oncology Plunges 42% on Ending Development of Lead Drug

Zacks
·
22 Mar

Akebia Stock Drops 28% on Pricing of $50M Common Stock Offering

Zacks
·
22 Mar

Analysts Offer Insights on Healthcare Companies: 89bio (ETNB), Gain Therapeutics (GANX) and Boston Scientific (BSX)

TIPRANKS
·
20 Mar

Goldman Sachs Initiates Coverage on 89bio With Neutral Rating, $11 Price Target

MT Newswires Live
·
14 Mar

89bio Initiated at Neutral by Goldman Sachs

Dow Jones
·
14 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Metropolitan Bank, Fossil, MeiraGTx

Reuters
·
13 Mar

Citi says SMid biotechs alternative to large caps as it starts coverage

Investing.com
·
13 Mar

89Bio Shares up 2% After Citigroup Initiates Coverage With 'Buy' Rating

THOMSON REUTERS
·
13 Mar

89Bio Shares up 3.6% Premarket After Citigroup Initiates Coverage With 'Buy' Rating

THOMSON REUTERS
·
13 Mar

BUZZ-Citi initiates coverage on 89bio with 'buy' rating on potential for MASH therapy

Reuters
·
13 Mar

Citigroup Initiates 89bio Inc at Buy With $25 Price Target

MT Newswires Live
·
13 Mar

BUZZ-Citi starts coverage on 'insulated' SMid biotechs amid healthcare policy uncertainty

Reuters
·
13 Mar

Is 89BIO (ETNB) Stock Outpacing Its Medical Peers This Year?

Zacks
·
06 Mar

Evercore ISI Sticks to Its Buy Rating for 89bio (ETNB)

TIPRANKS
·
06 Mar

Analysts Conflicted on These Healthcare Names: Cytokinetics (CYTK), Warby Parker (WRBY) and 89bio (ETNB)

TIPRANKS
·
03 Mar

Bank of America Securities Keeps Their Buy Rating on 89bio (ETNB)

TIPRANKS
·
02 Mar

89Bio Inc. Faces Financial Risks Amid Market Challenges for Approved Products

TIPRANKS
·
01 Mar

Analysts Are Bullish on Top Healthcare Stocks: 89bio (ETNB), Lemaitre Vascular (LMAT)

TIPRANKS
·
01 Mar

89bio Price Target Cut to $21.00/Share From $29.00 by HC Wainwright & Co.

Dow Jones
·
01 Mar